# A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects

> **NCT05072535** · PHASE1 · COMPLETED · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HA121-28 tablet B
- **DRUG:** HA121-28 tablet A

## Key facts

- **NCT ID:** NCT05072535
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-08
- **Primary completion:** 2021-12-19
- **Final completion:** 2022-03-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05072535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05072535, "A Study to Evaluate Relative Bioavailability and Food-Effect of HA121-28 Tablet B in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05072535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*